However, a short splicing variant of TIA-1 expressed in human colon cancer has been shown to exert the opposite effects by enhancing tumor growth, angiogenesis, and chemoresistance, adding complexity to the participation of SG proteins in cancer (Hamdollah Zadeh et al., 2015; Aulas et al., 2020). This evidence concerns the gene TIA1 and neoplasm.